Oren Elmaliah
Patrimonio netto: 20 150 $ in data 31/05/2026
Patrimonio netto: 20 150 $ in data 31/05/2026
Oren Elmaliah currently works at Presstek LLC, as Chief Financial Officer-Israel from 2017, Enlivex Therapeutics Ltd., as Controller from 2017, and My Size, Inc., as Chief Financial Officer from 2025.
Mr. Elmaliah also formerly worked at My Size, Inc., as Independent Director from 2017 to 2025 and Bioblast Pharma Ltd., as Chief Financial Officer & Controller.
Mr. Elmaliah received his undergraduate degree in 2011 from Tel-Aviv University and graduate degree in 2016 from Tel-Aviv University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
MY SIZE, INC. 0,67% | 21/05/2026 | 32.500 ( 0,67% ) | 20 150 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENLIVEX LTD. | Comptroller/Controller/Auditor | 01/02/2017 |
| MY SIZE, INC. | Direttore Finanziario/CFO | 01/04/2025 |
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Corporate Officer/Principal | 01/01/2017 |
| Società | Posizione | Fine |
|---|---|---|
| MY SIZE, INC. | Direttore/Membro del Consiglio | 06/03/2025 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Producer Manufacturing |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
My Size, Inc.
My Size, Inc. Internet Software/ServicesTechnology Services Engages in the development of smart phone application | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale